According to EyePoint Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.64. In 2022 the company made an earnings per share (EPS) of NZ-$4.84 a decrease over its 2021 EPS that were of NZ-$3.58.